Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study Program to Investigate the Effectiveness of Aflibercept 8 mg Used in DME and nAMD in a Real-world Setting

NCT06075147 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06075147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06075147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study Program to Investigate the Effectiveness of Aflibercept 8 mg Used in DME and nAMD in a Real-world Setting
Lead sponsor
Bayer
Phase
Observational
Overall status
Active, not recruiting
Start date
February 15, 2024
Completion date
January 31, 2028
Enrollment
2,500 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macula edema (dme), neovascular age-related macular degeneration (namd), visual impairment